<?xml version="1.0" encoding="UTF-8"?>
<p>MPV causes severe disease in children with comorbid conditions such as cardiac and pulmonary disease or prematurity [
 <xref ref-type="bibr" rid="CR259">259</xref>â€“
 <xref ref-type="bibr" rid="CR263">263</xref>]. A prospective 1-year study of hospitalized children found that 34 % of patients with MPV had a history of prematurity, chronic lung disease, complex congenital heart disease, or immunodeficiency [
 <xref ref-type="bibr" rid="CR264">264</xref>]. Vicente et al. detected MPV by RT-PCR in 6 % of adults &gt;64 years old with acute exacerbations of COPD; none had other pathogens identified by culture or PCR [
 <xref ref-type="bibr" rid="CR265">265</xref>]. A Canadian study found that 4 % of hospitalized adults with community-acquired pneumonia or COPD exacerbations tested positive for MPV, all with comorbid conditions; one also had influenza A and 
 <italic>S. pneumoniae</italic> [
 <xref ref-type="bibr" rid="CR266">266</xref>]. RSV was present in 9 % and influenza A in 6 % of the cohort. MPV was detected in 12 % of adults hospitalized for COPD exacerbation during one winter in Connecticut, none with other viruses co-detected; RSV was present in 8 % and influenza A in 4 % of the entire cohort [
 <xref ref-type="bibr" rid="CR267">267</xref>].
</p>
